January 12, 2009
FREMONT, Calif., Jan. 12 -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art gene expression, genotyping, cell biology and stem cell research systems, today announced that academic researchers have successfully demonstrated the performance of the company's SmartChip(TM) Real-Time PCR System in the initial phase of the platform's ongoing alpha testing program. [...]
Illumina and Oxford Nanopore Enter into Broad Commercialization Agreement
January 12, 2009
Illumina (NASDAQ:ILMN) and Oxford Nanopore Technologies (“Oxford Nanopore”) today announced a strategic alliance including a commercialization agreement and equity investment. Under the terms of the commercialization agreement, Illumina will exclusively market, sell, distribute, and service BASE™ Technology products developed by Oxford Nanopore for DNA sequencing into the research and diagnostic markets on a worldwide basis. [...]
January 12, 2009
Expands BD GeneOhm(TM) Assay Menu to Detect Major Healthcare-Associated Infections (HAIs) SAN DIEGO, Jan. 12 -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX) , announced today it has received clearance from the U.S. Food and Drug Administration to market the BD GeneOhm(TM) Cdiff molecular assay for the rapid detection of [...]
Waters Corporation Updates Business Conditions
January 12, 2009
MILFORD, Mass.--Jan. 12, 2009--Waters Corporation (NYSE: WAT) announced today that fourth quarter 2008 preliminary sales are approximately $418 million. On December 11, 2008, the Company revised its fourth quarter 2008 sales and earnings outlook due to anticipated reduced sales volume resulting from weaker global economic conditions, constrained capital spending and unfavorable foreign currency translation impacts. [...]
January 12, 2009
Illumina (NASDAQ:ILMN) today announced that researchers at Duke University Medical Center will utilize Illumina’s Genome Analyzer to study the resistance to HIV infection among 50 individuals that were highly exposed to the virus, but who remain uninfected. Duke University researchers will sequence the complete genome of at least 50 individuals with the desired phenotype. David [...]
Danaher Announces Executive Appointments
January 12, 2009
WASHINGTON, Jan. 12 -- Danaher Corporation (NYSE: DHR - News) announced today that David Martyr, Jonathan Clark, Kevin Layne, Richard McBee and Gregory Beason have each been appointed Vice President and Group Executive of Danaher. H. Lawrence Culp, Jr., President and Chief Executive Officer of Danaher, stated, "I am pleased to be able to make [...]
January 12, 2009
Milestone Achieved A Year Ahead of Schedule ST. LOUIS and RICHMOND, Calif., Jan. 12 -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced it has reached a major production capacity milestone as part of its agreement with Sigma-Aldrich Corporation (Nasdaq: SIAL) to commercialize zinc finger nuclease reagents (ZFNs) for research applications. The milestone triggers a payment [...]
January 12, 2009
Micromeritics’ GeoPyc 1360 Density Analyzer is an ideal tool for the determination of the bulk density of roller compactions and the ribbon created during the process Norcross, GA - 1/12/2009 -- Roller compactors have become commonplace in the production of solid dosage pharmaceuticals. Low API content formulations can be problematic if the appropriate steps are [...]
January 12, 2009
UPPSALA, Sweden, January 13 -- Beactica AB, the Swedish fragment-based drug discovery company, today announced a new research collaboration agreement with GE Healthcare (Chalfont St. Giles, UK), the world leading provider of molecular interaction analysis tools, and Uppsala University (Sweden). The collaboration combines Beactica's unique approach to fragment-based drug discovery and GE Healthcare's Biacore(TM) technology [...]
Millipore Corporation Supports President-Elect Obama’s Plans to Review Stem Cell Research Policy
January 12, 2009
BILLERICA, Mass.--Millipore Corporation (NYSE:MIL - News), a leading provider of technologies, tools and services for the global life science industry, today announced it would support President-elect Barack Obama’s plans to review and possibly reverse an executive order that currently restricts federal funding for embryonic stem cell research. The comments were made by Millipore Chairman, President [...]
